Yüklüyor......
EGFR-TKI plus brain radiotherapy versus EGFR-TKI alone in the management of EGFR-mutated NSCLC patients with brain metastases
BACKGROUND: It has been confirmed that epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) presented better efficacy than brain radiotherapy (brain RT) in the treatment of brain metastasis (BM) in EGFR mutated NSCLC patients. However, whether the combination of EGFR-TKIs and brai...
Kaydedildi:
| Yayımlandı: | Transl Lung Cancer Res |
|---|---|
| Asıl Yazarlar: | , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
AME Publishing Company
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6626863/ https://ncbi.nlm.nih.gov/pubmed/31367540 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2019.06.12 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|